HIV testing and same-day PrEP navigation in New York

Confidential HIV testing with a care plan matched to your exposure timing, test type, symptoms, and prevention goals.

If the result is negative, the same visit can include PrEP counseling and next-step navigation. If a recent exposure was within 72 hours, urgent PEP comes first.

Exposure within 72 hours? Ask for PEP now

An HIV test cannot rule out infection immediately after exposure. If a possible exposure happened within the past 72 hours, seek an urgent PEP evaluation instead of waiting for a later test.

Key clinical guidance

These points affect medication safety, test timing, or follow-up. The linked primary guidance supports each summary.

Testing depends on the window period

No HIV test detects infection immediately. Typical CDC windows are 10 to 33 days for NAT and 18 to 45 days for a laboratory antigen/antibody test, with longer windows for rapid and antibody-only tests.

Source: CDC HIV testing guidance

Same-day PrEP requires a complete testing pathway

New York guidance uses a rapid HIV test plus laboratory antigen/antibody and HIV RNA testing unless qualifying laboratory results exist from the prior seven days. Pending results must be reviewed and acted on within seven days.

Source: New York State PrEP clinical guideline

Rapid HIV treatment after diagnosis

When HIV is confirmed, New York's Rapid ART guideline supports offering treatment as soon as possible, including on the day of diagnosis or the first clinic visit when clinically appropriate.

Source: New York State Rapid ART guideline

The essentials at a glance

Three main test types

HIV testing may use an antibody test, antigen/antibody test, or nucleic acid test based on the situation.

Window periods differ

No HIV test can detect infection immediately. The right repeat-test date depends on the test and exposure timing.

Prevention next steps

A negative result can lead directly to oral PrEP, Apretude, Yeztugo, PEP, or another prevention plan when appropriate.

What to expect from care

The exact plan depends on your history, test results, coverage, and medication choice. These are the usual steps.

Exposure and symptom review

Share the most recent exposure date, prior tests, current symptoms, and any recent PrEP or PEP use.
Select the appropriate HIV test

The clinician chooses rapid blood testing, laboratory antigen/antibody testing, HIV RNA testing, or a combination based on timing and clinical need.
Interpret the result in context

A negative early result may require repeat testing. A reactive screening result requires confirmatory testing before a final diagnosis.
Choose the next care path

Discuss urgent PEP, daily oral PrEP, Apretude, Yeztugo, STI testing, or HIV treatment linkage as indicated.
Schedule follow-up

Set the repeat-test, PrEP monitoring, or treatment-linkage plan before the visit ends.

Which HIV test may be used

A laboratory antigen/antibody test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A rapid fingerstick antigen/antibody test usually detects infection 18 to 90 days after exposure. Antibody tests usually detect infection 23 to 90 days after exposure. A nucleic acid test, or NAT, can usually detect HIV 10 to 33 days after exposure.

These are typical CDC window ranges, not a guarantee for an individual result. Recent PrEP or PEP can affect test interpretation. A clinician will tell you whether repeat antigen/antibody or RNA testing is needed.

Tell the clinician the exact exposure date when possible.
Report fever, rash, sore throat, swollen glands, or flu-like symptoms.
Share any PrEP or PEP taken in recent months.
Bring outside results so unnecessary repeat testing can be avoided.

What a same-day PrEP pathway can include

For same-day PrEP initiation in New York, clinicians obtain a rapid HIV test and order a laboratory antigen/antibody test plus HIV RNA unless qualifying laboratory results are available from the prior seven days. Medication may start while results are pending when the rapid result and clinical assessment support it, but the results must be reviewed and acted on within seven days.

The visit can also include kidney, hepatitis B, STI, or lipid testing depending on the PrEP option. An exposure within the prior 72 hours requires urgent PEP assessment before PrEP.

Same-day navigation does not always mean medication starts immediately. Recent exposure, acute symptoms, prior long-acting PrEP, a discordant test, or another health concern may require additional testing first. The goal is a clear plan, not a rushed prescription.

Oral PrEP uses a daily tablet.
Apretude uses provider-administered injections every two months after initiation.
Yeztugo uses two provider-administered injections every six months after starter dosing.
PEP is the urgent 28-day course used after a recent possible exposure.

Confidential testing, reactive results, and linkage to care

Nao Medical provides confidential clinical testing. Confidential testing is recorded in the medical record and protected by privacy law; it is different from anonymous testing that does not use identifying information.

A reactive screening test is not the final diagnosis. Follow-up testing is required. If HIV is confirmed, prompt linkage to an experienced treatment team is the next step. New York's Rapid ART guideline supports offering treatment as soon as possible, including on the day of diagnosis or the first clinic visit when clinically appropriate.

Ask how and when results will be delivered.
Keep contact information current for follow-up.
Do not interpret a reactive screening result without confirmatory testing.
Ask about insurance, self-pay, or public testing options before declining needed care.

Find HIV testing and PrEP navigation

Choose a clinic for directions and local details, then use the HIV testing booking path to confirm current appointments and follow-up options.